Ensign Peak Advisors
LH icon

Ensign Peak Advisors’s Labcorp LH Stock Holding History

Ensign Peak Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
13,737
+3,977
+41% +$1.05M 0.01% 620
2026
Q1 		$2.6M Sell
9,760
-131
-1% -$35.5K ﹤0.01% 659
2025
Q4 		$2.48M Sell
9,891
-11,599
-54% -$3.08M ﹤0.01% 664
2025
Q3 		$6.17M Sell
21,490
-7,190
-25% -$1.93M 0.01% 555
2025
Q2 		$7.53M Sell
28,680
-5,661
-16% -$1.38M 0.01% 545
2025
Q1 		$7.99M Buy
34,341
+776
+2% +$188K 0.02% 520
2024
Q4 		$7.7M Sell
33,565
-1,515
-4% -$348K 0.01% 537
2024
Q3 		$7.84M Buy
35,080
+220
+0.6% +$48.4K 0.01% 519
2024
Q2 		$7.09M Sell
34,860
-715
-2% -$145K 0.01% 542
2024
Q1 		$7.77M Buy
35,575
+4,129
+13% +$910K 0.01% 512
2023
Q4 		$7.15M Buy
31,446
+233
+0.7% +$48.9K 0.01% 532
2023
Q3 		$6.28M Sell
31,213
-3,091
-9% -$652K 0.01% 510
2023
Q2 		$7.11M Sell
34,304
-28,595
-45% -$5.55M 0.01% 500
2023
Q1 		$12.4M Buy
62,899
+1,493
+2% +$307K 0.03% 368
2022
Q4 		$12.4M Sell
61,406
-8,128
-12% -$1.59M 0.03% 363
2022
Q3 		$12.2M Sell
69,534
-15,459
-18% -$3.16M 0.03% 342
2022
Q2 		$17.1M Sell
84,993
-15,389
-15% -$3.28M 0.04% 290
2022
Q1 		$22.7M Buy
100,382
+24,025
+31% +$5.65M 0.05% 273
2021
Q4 		$20.6M Buy
76,357
+46,432
+155% +$11.5M 0.04% 313
2021
Q3 		$7.24M Sell
29,925
-3,071
-9% -$774K 0.02% 515
2021
Q2 		$7.82M Buy
32,996
+640
+2% +$146K 0.02% 495
2021
Q1 		$7.09M Sell
32,356
-12,253
-27% -$2.46M 0.02% 508
2020
Q4 		$7.8M Sell
44,609
-52,493
-54% -$9.07M 0.02% 482
2020
Q3 		$15.7M Sell
97,102
-113,218
-54% -$17.9M 0.04% 355
2020
Q2 		$30M Sell
210,320
-79,177
-27% -$11M 0.08% 207
2020
Q1 		$31.4M Buy
289,497
+21,231
+8% +$3.06M 0.11% 143
2019
Q4 		$39M Buy
+268,266
New +$38.7M 0.1% 165

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ensign Peak Advisors's LH Position: Q2 2026 in Review

Ensign Peak Advisors increased its Labcorp (LH) stake by 41% in Q2 2026, buying an estimated $1.05M and bringing the position to 13,737 shares worth $3.85M. The position accounts for 0.01% of the portfolio, ranked #620.

Ensign Peak Advisors first reported a position in LH in Q4 2019 and has held it in 27 quarters since. The position peaked at $39M in Q4 2019. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ensign Peak Advisors held 13,737 shares of Labcorp worth $3.85M as of Q2 2026.
  • Ensign Peak Advisors bought 3,977 Labcorp shares in Q2 2026, an estimated $1.05M.
  • Labcorp made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #620 holding.
  • Ensign Peak Advisors first reported a position in Labcorp in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Labcorp position peaked at $39M in Q4 2019.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.